483 Tedor Pharma Jan 2019

483 Tedor Pharma Jan 2019

Robert Martin FDA$119.00 - Available Now

FDA investigators audited the Tedor Pharma - Cumberland, RI, United States facility and issued inspectional observations (via FDA 483) on 31 Jan 2019.

Product details

  • Category: Human Drugs
  • Inspection end: 31 Jan 2019
  • Location: Cumberland, United States
  • FEI: 3003855180
Add To Cart